Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (39)

2024

  1. Current management of SARS-CoV-2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey

    Transplant Infectious Disease, Vol. 26, Núm. 2

  2. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation

    American Journal of Transplantation

  3. Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

    Mycoses, Vol. 67, Núm. 1

  4. Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324

2023

  1. A joint program of antimicrobial stewardship and hospital-acquired infection control to reduce healthcare-associated infections after kidney transplantation: The Hipomenes study

    American Journal of Transplantation, Vol. 23, Núm. 12, pp. 1949-1960

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years

    GeroScience, Vol. 45, Núm. 1, pp. 543-553

  4. Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 9, Núm. 10, pp. E1536

  5. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  6. Comparison of intracellular cytokine staining versus an ELISA-based assay to assess CMV-specific cell-mediated immunity in high-risk kidney transplant recipients

    Journal of Medical Virology, Vol. 95, Núm. 4

  7. Cytokine and Chemokine Secretome and Risk of CMV Infection Following Discontinuation of Valganciclovir Prophylaxis

    Transplant International

  8. Dynamics of Human Anelloviruses in Plasma and Clinical Outcomes Following Kidney Transplantation

    Transplantation, Vol. 107, Núm. 2, pp. 511-520

  9. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

    American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034

  10. Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial

    BMJ open, Vol. 13, Núm. 9, pp. e072121

  11. Invasive aspergillosis in liver transplant recipients

    Transplant Infectious Disease, Vol. 25, Núm. 3

  12. Isavuconazole for Treating Invasive Mould Disease in Solid Organ Transplant Recipients

    Transplant International, Vol. 36

  13. Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

    Transplantation, Vol. 107, Núm. 3, pp. 762-773

  14. Lung abscess and empyema in a heart transplant recipient from Thailand

    Transplant Infectious Disease, Vol. 25, Núm. 1

  15. Mortality due to carbapenemase-producing GNB in transplantation: Are risk scores useful?

    Transplant Infectious Disease

  16. Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience

    Journal of Medical Virology, Vol. 95, Núm. 9